We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Chiltern

News List

Ergomed Proposes Appointment of Former Chiltern CEO contractpharma
July 11, 2019
Dr. Jim Esinhart to be appointed as a Non-Executive Director of the Company.
LabCorp completes acquisition of Chiltern for $1.2bn pharmaceufical-technology
September 05, 2017
US-based global life sciences company LabCorp has completed the acquisition of Chiltern, a specialist contract research organisation (CRO), for approximately $1.2bn.
LabCorp to acquire Chiltern for $1.2 billion in cash biospectrumasia
August 04, 2017
Chiltern is a leading CRO among emerging-to-mid biopharma customers, with forecasted 2017 revenue and adjusted EBITDA of approximately $550 million and $95 million, respectively, and backlog of approximately $1.0 billion.
LabCorp to buy Chiltern for approximately $1.2bn pharmaceutical-technology
August 02, 2017
US-based global life sciences company LabCorp is set to acquire Chiltern, a specialist contract research organisation (CRO), in an all-cash transaction valued at approximately $1.2bn.
Chiltern Acquires Japanese CRO contractpharma
June 01, 2017
Offers expertise in establishing regulatory and development pathways for Japan and Pan Asian clinical trials